Radical prostatectomy versus deferred treatment for localised prostate cancer

RWM Vernooij, M Lancee, A Cleves… - Cochrane Database …, 2020 - cochranelibrary.com
Background Prostate cancer is a common cancer but is oftentimes slow growing. When
confined to the prostate, radical prostatectomy (RP), which involves removal of the prostate …

Advances in prognostic methylation biomarkers for prostate cancer

D Lam, S Clark, C Stirzaker, R Pidsley - Cancers, 2020 - mdpi.com
Simple Summary Prostate cancer is a major cause of cancer-related death in men
worldwide. There is an urgent clinical need for improved prognostic biomarkers to better …

PSA Based Biomarkers, Imagistic Techniques and Combined Tests for a Better Diagnostic of Localized Prostate Cancer

VC Munteanu, RA Munteanu, D Gulei, VH Schitcu… - Diagnostics, 2020 - mdpi.com
Prostate cancer represents the most encountered urinary malignancy in males over 50 years
old, and the second most diagnosed after lung cancer globally. Digital rectal examination …

[PDF][PDF] EAU-EANM-ESTRO-ESUR-SIOG

N Mottet, P Cornford… - … on prostate cancer, 2020 - medi-guide.meditool.cn
The Prostate Cancer (PCa) Guidelines Panel have prepared this guidelines document to
assist medical professionals in the evidence-based management of PCa. It must be …

A narrative overview of active surveillance for clinically localised prostate cancer

AS Bates, N Kostakopoulos, J Ayers, M Jameson… - Seminars in oncology …, 2020 - Elsevier
Background-Active surveillance (AS) is a strategy employed as an alternative to immediate
standard active treatments for patients with low-risk localised prostate cancer (PCa). Active …

Optimizing psychosocial support in prostate cancer patients during active surveillance

K Donachie, E Cornel, M Adriaansen… - … Journal of Urological …, 2020 - Wiley Online Library
What are the psychosocial support needs of prostate cancer (PCa) patients undergoing
active surveillance (AS)? The preferred management strategy for low‐risk PCa (LR‐PCa) is …

Expert group consensus opinion on prostate cancer diagnosis and management in India: Part 1 of 2

A Ghose, M Khochikar, R Sabnis, NM Parmar… - The Korean Journal of …, 2020 - e-juo.org
Purpose To evaluate Indian literature, clinical practice and develop consensus opinion on
various aspects of prostate cancer diagnosis and management in order to assist medical …

Factores que influyen en la mortalidad cáncer específica en las distintas etapas de la secuenciación en el tratamiento del cáncer de próstata resistente a la castración

AV Ojeda Claro - 2020 - gredos.usal.es
[ES] Actualmente las novedosas terapias dirigidas al eje del receptor androgénico
(Abiraterona, enzalutamida, apalutamida y darolutamida) han sido aprobadas con categoría …

MRI and Active Surveillance for Prostate Cancer

A Porreca, M Colicchia, GM Busetto, M Ferro - Diagnostics, 2020 - mdpi.com
Since the introduction of Prostate-Specific Antigen (PSA) screening, prostate cancer
mortality has decreased [1], but over-diagnosis and overtreatment of this neoplasm have …

Noninvasive treatment of organ-confined prostate cancer in elderly patients—results of the HAROW study

J Herden, EA Boedefeld, L Weissbach - Der Urologe, 2020 - Springer
Background Noninvasive treatment options such as active surveillance (AS), watchful
waiting (WW), and hormone deprivation therapy (HT) are particularly important in elderly …